Meteora Capital’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Meteora Capital’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,000	Closed	-$1.65K	–	175
2024 Q3	$1.65K	Hold	25,000	–	–	﹤0.01%	186
2024 Q2	$2.2K	Hold	25,000	–	–	﹤0.01%	220
2024 Q1	$1.79K	Hold	25,000	–	–	﹤0.01%	243
2023 Q4	$950	Hold	25,000	–	–	﹤0.01%	298
2023 Q3	$1.03K	Hold	25,000	–	–	﹤0.01%	341
2023 Q2	$1.18K	Hold	25,000	–	–	﹤0.01%	349
2023 Q1	$3.89K	Buy	+25,000	New	+$3.79K	﹤0.01%	341

Other funds holding LSBPW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

VAM

Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

OCM

Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Meteora Capital's LSBPW Position: Q4 2024 in Review

Meteora Capital sold out of LakeShore Biopharma Warrants (LSBPW) in Q4 2024, closing a stake of 25,000 shares — an estimated $1.65K sold.

Meteora Capital first reported a position in LSBPW in Q1 2023 and held it in 7 quarters. The position peaked at $3.89K in Q1 2023. 18 funds tracked by Wall St. Rank hold LSBPW as of Q4 2024.

Meteora Capital reported no remaining LakeShore Biopharma Warrants position as of Q4 2024 after selling out during the quarter.
Meteora Capital sold 25,000 LakeShore Biopharma Warrants shares in Q4 2024, an estimated $1.65K.
Meteora Capital first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 7 quarters.
Meteora Capital's LakeShore Biopharma Warrants position peaked at $3.89K in Q1 2023.
18 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q4 2024.

Based on Meteora Capital's 13F filing for Q4 2024, filed 14 Feb 2025.